Girls used as Guinea Pigs in HPV Trials Admits GSK By Jamie Published: 08 July 2009 10:05 PM MSTPosted in: Disease, Featured, HPV, News Comments [0] Digg it! Facebook Edit Post July 05, 2009 Christina England Full Article Here. We have always suspected it and now they admit it,GSK are using young girls (as young as 9 in some areas) as human Guinea Pigs in HPV vaccine Cervarix trials. This was only discovered after reading a document that was meant for 'Scientific Background and Informational Purposes only' Cervarix GlaxoSmithKline´s Cervical Cancer Candicate Vaccine Mandate. Media Backgrounder makes very disturbing reading as it states exactly what trials are to be carried out, with one particular very interesting line "Phase III Trials Phase III studies are underway in 37 countries with more than 39,000 subjects planned." So this appears to prove that all our children are part of one big experiment to enable the drug companies to line their pockets whilst they sit back and watch what happens to our children. Whilst trawling the Internet a fellow member of ICAP also came up with this gem of a document which also appears to prove that our children are part of trials. The document is the Presentation of advisory report Vaccination against cervical cancer from the health Council of the Netherlands to the Minister of Health, Welfare and Sport This is an official political document. It is called 'Vaccination against Cervical Cancer' and it was accompanied with a letter addressed to the Minister of Health, Welfare and Sport in the Netherlands, from the Health Council. Interestingly the report outlines some very alarming points. The report discusses the differences between the two HPV vaccinations Cervarix and Gardasil. It States:- "Both vaccines are designed to provide immunity against HPV-16 and 18: the two types of the virus responsible for about 70 per cent of cervical cancer cases. Gardasil also provides protection against HPV-6 and 11, which together cause nearly all genital warts. Broader-spectrum vaccines capable of protecting against hrHPVs other than HPV-16 and 18 may become available in due course. The vaccines differ from one another in terms of the adjuvants (vaccine-aiding agents) they utilise. Gardasil uses the well-established adjuvant aluminium hydroxyphosphate sulphate, while Cervarix uses the equally widely employed aluminium hydroxide, but in combination with monophosphoryl lipid A, a chemically modified lipopolysaccharide, that influences the innate immune system. The latter complex is known as ASO4. Cervarix stimulates higher levels of antibody production, but the significance of this phenomenon for its protective effect is not known." The report states that there is no real knowledge to how long the vaccine lasts or if a booster will be needed or if in fact it does protect against cervical cancer. "Conclusions Vaccination protects against persistent infection and the precursors of cervical cancer The initial effect of vaccination is favourable: vaccination leads to the formation of antibodies against the target hrHPVs and thus to protection against infection by those hrHPVs. This in turn brings about a major short-term reduction in the incidence of the precursors of cervical cancer. It is known that the development of such precursors is a prerequisite for the subsequent development of the cancer. Vaccination against cervical cancer itself. However, whether vaccination does in fact protect against cervical cancer will not be known for many years to come." Lovely isn't it? Then it states:- "It is not yet clear whether booster vaccinations will be needed The duration of the protection afforded by vaccination has yet to be determined.It is known, however, that high antibody levels persist for at least five years and that immunological memory is created. Protection is required, however, for several decades. The possibility that re-vaccination will be needed in order to provide such prolonged protection cannot be excluded at the present time." It carries on "Although the available data provide an incomplete picture of the effectiveness of HPV vaccination, they are sufficient to support the expectation of significant health benefit: vaccination leads to fewer infections and thus to a reduced incidence of the precursors of cervical cancer. We may therefore move on to the next criterion. Thus, this chapter of the report considers whether vaccination might have any adverse effects that offset the attainable health benefit. Although the trials so far conducted have involved the administration of HPV vaccine to thousands of women (nearly 12,000 have been given Gardasil and more than 16,000 Cervarix),the numbers are small compared with those that would be involved in general vaccination.If vaccination were made available to all twelve-year-old girls in the Netherlands,that would mean treating roughly 100,000 young people a year. Certainty regarding the vaccine´s safety and insight into any rare side-effects that it might have are therefore very important." For me however, the hightlight of whole report and letter is in the Executive Summary at the beginning where it states quite clearly:- "With regard to safety, the third assessment criterion, there is currently no reason to suppose that the vaccine has any adverse events that might preclude its inclusion in the NIP. Nevertheless, the possibility cannot be excluded that, if it were administered to large numbers of people, relatively uncommon adverse events might come to light in due course. This underlines the importance of careful monitoring following the introduction of this form of vaccination." I would particularly like to draw your attention to this phrase "relatively uncommon adverse events might come to light in due course" In other words the more they vaccinate the more likely it is that a serious adverse reaction will show up. That is really great news to all parents out there with children about to be vaccinated with Cervarix or Gardasil. Your children are part of a nationwide test but it is OK because if your child gets very bad reaction it will help determine the safety of the vaccine. I am sure that will be a great comfort to mothers of children like Ashleigh Cave who is still in hospital after a Cervarix vaccination. She has now been in hospital for 9 months, is just beginning to be able to put a very small amount of weight on her legs, cannot stand unaided and has recently lost bladder control at 13. The news gets better for all you parents out there because Suzanne Garland who is the director of Microbiology and Infectious Diseases at the Royal Woman's Hospital in Melbourne has decided she wants to include babies in the HPV vaccine trials. She is on the advisory boards for both rival companies Merck and Glaxo Smith Kline and has proposed to test cervical cancer vaccines in babies, with a view to adding the vaccine to the infant immunisation program. This is according to The India Times in 2007 Suzanne Garland has a special interest in the management of herpes in the pregnant woman and the neonate. She is an advisor to World Health Organisation in the area of sexually transmitted infection diagnosis and the prophylactic HPV vaccine Obs-Gyne Exhibition & Congress Speakers Tackle Cervical Cancer Vaccine Issues And Encourage Advocacy So she has no real conflicts of interest there then does she? Not only is she on both boards of advisers for Merck and GSK but she is an advisor to WHO! It appears that no matter who advises Governments on vaccinations whether it is WHO or the JCVI,the members have strong links and alliances to the pharmaceutical companies who manufacture the vaccines, therefore, how can the general public trust the people who tell us the vaccines are safe? As we have seen we are all just human Guinea Pigs to them, of course they are safe! www.autismlarimer.org aslc@autismlarimer.org 970-377-9640 If you do not wish to receive future e-mails or newsletters, please reply to this message with 'Remove' in the subject line.

July 08, 2009 Chronic Seizures and Immune System You might want to check David Kirby's Autism One Presentation (HERE) for more about the microglial cells mentioned in this article. Read the full article at SCIENCE DAILY. ScienceDaily (July 7, 2009) — Chronic seizures caused by traumatic head injuries may result from chemicals released by the brain's immune system attempting to repair the injured site, according to a study led by the University of Colorado at Boulder. The findings could help prevent one of the most common forms of adult epilepsy, called acquired epilepsy, which is often found in people who have suffered a brain injury or infection, according to CU-Boulder psychology and neuroscience Professor Daniel Barth, the study's chief author. For decades researchers have focused on neurons as the culprits in seizures, which can be characterized as debilitating "electrical storms" in the brain. However, recent research has shown that micro-glial cells may play a major role in seizures. Researchers have found that glial cells, which are supportive cells that also constitute a major part of the brain's immune system, cluster within areas in the brain when a severe brain injury has occurred. www.autismlarimer.org aslc@autismlarimer.org 970-377-9640 If you do not wish to receive future e-mails or newsletters, please reply to this message with 'Remove' in the subject line.

Celiac Disease Presenting as Autism The Journal of Child Neurology published a special article online June 29, 2009 (published ahead of printing) entitled "Celiac Disease Presenting as Autism." The article is a case study of a 5-year-old boy diagnosed with autism and celiac disease. The boy was described as "an increasingly picky eater and would reject food on the basis of taste, smell, or appearance." He had severe language problems, as well as gastrointestinal symptoms including bloating, belching, abdominal pain, nausea, vomiting, and diarrhea. He had deficiencies in fat-soluble vitamins (vitamins A, D, and E) and fatty acids (omega 3, omega 6, saturated fat), as well as low coenzyme Q10 and folate. Upon being assessed and diagnosed with celiac, the boy was put on a gluten-free diet and nutritional supplementation based on deficiencies. "Fruits and vegetables were juiced to make nutrients easier to absorb, and fat-soluble vitamins, omega 3 fatty acids (in the form of cod liver oil), omega 6 fatty aids, and folic acid were given as supplements." According to the published article, "The patient's gastrointestinal symptoms rapidly resolved, and signs and symptoms suggestive of autism progressively abated." "Within 1 month, the boy's gastrointestinal symptoms were relieved and his behavior had changed dramatically. The mother excitedly reported that for the first time, her 5-year-old boy became progressively more communicative and told her that he loved her. Within 3 months, his functioning had improve so much that he no longer required an individualized leaning program and was able to enter a normal classroom with no aide." The authors of the article postulate that nutrient deficiencies caused by malabsorption from celiac disease caused the symptoms of autism, as they stated, "This case is an example of a common malabsorption syndrome associated with central nervous system dysfunction and suggests that in some contexts, nutritional deficiency may be a determinant of developmental delay. It is recommended that all children with neurodevelopmental problems be assessed for nutritional deficiency and malabsorption syndromes." Genuis SJ, Bouchard TP. Celiac Disease Presenting as Autism. J Child Neurology Online First. Published on June 29, 2009 as doi:10.1177/0883073809336127 www.autismlarimer.org aslc@autismlarimer.org 970-377-9640 If you do not wish to receive future e-mails or newsletters, please reply to this message with 'Remove' in the subject line.

Television and Your Children TV for children - especially young children - is a very controversial subject these days. For good reason, many, many children watch Far Too Much TV! We believe our videos and DVDs, used appropriately, are wonderful teaching tools. Here are some guidelines to help you select and use educationally appropriate video & TV programming for your kids: Use Your Own Judgment - Your own judgment will often tell you what is "Good TV" and what is "Bad TV". If you are not sure what your child is learning from a program the answer is probably nothing! There isn't any independent agency for "educational" content. Producers can label almost any video as educational - regardless of real educational value. Is The Program Age Appropriate? - Another point to consider is age. What is educational for your infant, may well be mind-numbing for your 4 or 5 year old - and vice versa! The educational content of a video should be achievable - yet challenging. Spend Some Time Watching TV With Your Kids - Try not to use the TV as a Baby-sitter. Enjoy some programs with your child. See how he or she has progressed with the material contained in the video. Your involvement will help reinforce learning. Let Your Kids "Graduate" From a Video - Once the educational content of a video has been learned, that video is no longer educational. Many children become addicted to a book, a puzzle or a video. Once a child has mastered the material in a book, puzzle, or video introduce more challenging material. They will come to love the new just as much as the old. Look for Videos That Teach Specific Skills - Material that is labeled "stimulating" may have little to offer your child. Stimulation is found primarily through active exploration of the world around us. Be selective and choose videos that have a specific learning focus. Avoid Introducing "Entertainment Only" Videos Too Early - Introducing your child to videos that provide little educational content can make it very hard to get your child interested in educational TV fare. Just as you would not feed your child cookies before a meal - don't introduce "fluff" TV before introducing solid educational programming. Just like a cookie, this can spoil an appetite for better stuff! We believe TV should be used as a supplement to regular stimulation, love & fun. It is our belief that parents should be very, very selective about what they allow young children to watch, and also very careful about limiting the total quantity of TV viewed. The best way to assure that your child's viewing time is used well, is to spend time with your child while watching TV. Be sensitive to his or her skill level and choose material that is appropriate to his or her developmental stage. TV can be a great teaching tool - or it can be a big problem. How TV is used is up to you, the parent. www.autismlarimer.org aslc@autismlarimer.org 970-377-9640 If you do not wish to receive future e-mails or newsletters, please reply to this message with 'Remove' in the subject line.

M12 Lollipops

Testimonials for "revitaPop" MB12 Lollipops By Kim Stagliano You've got to check out the revitaPop, methylcobalamin (MB12) in a tasty lollipop.  I tried my first revitaPop at Autism One last month (HERE.) Holy cow! Within seconds I felt a distinct "ping" in my brain and I became more alert, bubbly and energetic. Trust me, if I hadn't felt anything I'd have smiled and walked away from the booth to go find coffee. Click HERE to view a quick video of testimonials from Autism One.  You'll see familiar faces, including Kimberly Linderman, yours truly and our Contributing Editor Abdulkadir Khalif. The revitaPop tastes great (I tried Pomegranate) is gluten and casein free and uses no artificial colors or flavors. I was really happy to learn from Dave Dobkin (that's he in the photo), that the folks at revitaPop employ people with developmental disabilities to sort, pack and ship the product.  And they support Generation Rescue and the new Rescue Family grant program. revitaPop was created by Stan Kurtz who also invented the MB12 Nasal Spray and is President of Generation Rescue . There is a patent pending on revitaPOP's novel administration of MB12.  Their first shipment sold out in days.  Their next shipment arrives this week.   Go to www.revitaPop.com to learn more.

RE: Autism Community Mourns Passing of Dr. Ted Carr

Autism Community Mourns Passing of Dr. Ted Carr Pioneer Psychologist Transformed Understanding and Treatment of Autism Behaviors   Bethesda, MD (June 22, 2009) -- The autism community lost a great leader this weekend, Dr. Edward Carr, who was killed by a drunk driver the afternoon of June 20. Dr. Carr, the Leading Professor in the Department of Psychology at the State University of New York at Stony Brook, was a top advisor to the Autism Society. We are deeply saddened by the loss of our friend and colleague and his wife, Ilene Wasserman, who was also killed in the crash, and we send our thoughts and prayers to their family.   Dr. Carr was recognized internationally for his research on new treatments for autism and related disabilities. He co-developed Functional Behavioral Assessment and Positive Behavior Support, a strategy for dealing with learning and behavior issues endorsed by the Individuals with Disabilities Education Act (IDEA). Dr. Carr wrote numerous articles on autism treatment and authored the best-selling book, Communication-Based Intervention for Problem Behavior (Paul H. Brookes, 1994). He has received numerous awards, including the Applied Research Award in Behavior Analysis (American Psychological Association, 2001) and the Distinguished Research Award for Career Achievement (ARC, 1999).   Dr. Carr was a strong supporter, valued contributor and beloved colleague at the Autism Society. As a member of the Autism Society's Panel of Professional Advisors, he was a frequent contributor to the Autism Advocate, most recently co-editing an issue on ABA therapy (http://www.autism-society.org/site/PageServer?pagename=autismadvocate_aba), which was one of his many areas of expertise. With Drs. Martha Herbert and Brenda Smith-Myles, Dr. Carr developed the Autism Society's Treatment Guided Research Initiative and was the main inspiration for the "Quality of Life" objectives the Society uses to develop and evaluate its programs. A frequent presenter at the Autism Society National Conference, Dr. Carr was scheduled to moderate this year's keynote panel on "The Future of Autism" on July 23. The panel will continue to be held in his honor.   "Ted was passionately committed to improving the quality of life for people with autism and their families," said Lee Grossman, President and CEO of the Autism Society. "Those of us who were privileged to work closely with him will miss his insights, his humor, his deep compassion and advocacy for people affected by autism. We will miss him greatly but we will ensure his legacy lives on."   "Dr. Ted Carr was a pioneer in the field of positive behavior supports and autism spectrum disorders. His focus on enhancing quality of life and understanding of the systemic issues surrounding behaviors forced practitioners to think more broadly when designing interventions," said Dr. Cathy Pratt, Chair of the Autism Society Board of Directors. "He was a gentle man and quiet innovator with a quick wit and amusing perspective. His work will truly live on and serve as an inspiration for generations to come."   Dr. Carr was Past President of the Association for Positive Behavior Support and a Fellow of the American Psychological Association and the American Association on Intellectual and Developmental Disabilities.   In Dr. Carr's honor, the Autism Society has set up a Tribute page for colleagues, friends and admirers to post their thoughts and messages on Dr. Carr at www.autism-society.org/ted_carr_memorial. The page will be shared with his family and colleagues.     Carin Yavorcik Media Specialist The Autism Society 301.657.0881 x 115 cyavorcik@autism-society.org www.autism-society.org   NOTICE: This message is confidential, intended for the named recipient(s) and may contain information that is (i) proprietary to the sender, and/or, (ii) privileged, confidential and/or otherwise exempt from disclosure under applicable Maryland and federal law, including, but not limited to, privacy standards imposed pursuant to the Health Insurance Portability and Accountability Act ("HIPAA").  Receipt by anyone other than the named recipient(s) is not a waiver of any applicable privilege.  If you have received this email in error, please delete it immediately.  Thank you in advance for your compliance with this notice.

Recipe: Crispy Rice Treats Rated - Not yet rated Rate this Recommend Rate this | Add your comment Add to Shopping List Add to Shopping List Select a shopping list Create a new list Name for new list: Cancel Items to add: 4 cups brown rice crisps cereal 2/3 cup raisins 1/2 cup smooth almond butter 5 tablespoons raw agave nectar 1 tablespoons vanilla extract 1/2 teaspoon ground cinnamon Cancel Makes 12 Almond butter, brown rice crisps, raisins and agave nectar give this classic treat a healthier update. Ingredients 4 cups brown rice crisps cereal 2/3 cup raisins 1/2 cup smooth almond butter 5 tablespoons raw agave nectar 1 tablespoons vanilla extract 1/2 teaspoon ground cinnamon Method Place cereal and raisins in a large mixing bowl. Heat almond butter and agave nectar over medium-low heat until the mixture is warm and thinned like syrup. Remove from heat and stir in vanilla and cinnamon. Pour over cereal and raisins and stir until completely coated. Spray a 7-by-11-inch baking dish with natural cooking spray. Transfer the cereal mixture to the baking pan. Pat it down with wet fingers to even out the top. Chill for an hour before cutting into squares. Keep chilled between servings. Nutrition Per serving (1 square/about 1oz/39g-wt.): 160 calories (60 from fat), 7g total fat, 0.5g saturated fat, 0mg cholesterol, 90mg sodium, 25g total carbohydrate (1g dietary fiber, 13g sugar), 3g protein www.autismlarimer.org aslc@autismlarimer.org 970-377-9640 If you do not wish to receive future e-mails or newsletters, please reply to this message with 'Remove' in the subject line.